| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/11/2023 | Aggarwal Gaurav | Director | Conversion | Tranche C Warrants (right to buy) | 18.6M | $0.74 | $13.8M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Aggarwal Gaurav | Director | Conversion | Tranche B Warrants (right to buy) | 11.6M | $0.59 | $6.9M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Aggarwal Gaurav | Director | Conversion | Tranche A Warrants (right to buy) | 12.8M | $0.54 | $6.9M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Aggarwal Gaurav | Director | Conversion | Series A-2 Preferred Stock | 13.4M | $0.00 | $0 | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Aggarwal Gaurav | Director | Conversion | Series A-1 Preferred Stock | 8.1k | $1,000.00 | $8.1M | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Aggarwal Gaurav | Director | Conversion | Common Stock | 3.5M | $0.00 | $0 | By Vivo Opportunity Fund Holdings, L.P. | 07/11/2023 |
| 07/11/2023 | Gupta Shalabh K. | CEO | Exercise | Common Stock | 104.6k | $0.00 | $0 | | 07/11/2023 |
| 07/11/2023 | Gupta Shalabh K. | CEO | Exercise | Series A-1 Convertible Preferred Stock | 50 | $0.49 | $24.5 | | 07/11/2023 |
| 07/11/2023 | Gupta Shalabh K. | CEO | Exercise | Warrant (right to buy | 79.3k | $0.54 | $42.8k | | 07/11/2023 |
| 07/11/2023 | Gupta Shalabh K. | CEO | Exercise | Warrant (right to buy) | 72k | $0.59 | $42.5k | | 07/11/2023 |
| 07/11/2023 | Gupta Shalabh K. | CEO | Exercise | Warrant (right to buy) | 115.3k | $0.74 | $85.3k | | 07/11/2023 |
| 07/11/2023 | Gupta Pramod | EVP, Pharmaceuticals and BD | Exercise | Series A-1 Convertible Preferred Stock | 20 | $0.49 | $9.8 | | 07/11/2023 |
| 07/11/2023 | Gupta Pramod | EVP, Pharmaceuticals and BD | Exercise | Warrant (right to buy | 31.7k | $0.54 | $17.1k | | 07/11/2023 |
| 07/11/2023 | Gupta Pramod | EVP, Pharmaceuticals and BD | Exercise | Warrant (right to buy) | 28.8k | $0.59 | $17k | | 07/11/2023 |
| 07/11/2023 | Gupta Pramod | EVP, Pharmaceuticals and BD | Exercise | Warrant (right to buy) | 46.1k | $0.74 | $34.1k | | 07/11/2023 |
| 07/11/2023 | Jermasek Douglas | EVP of Corporate Strategy | Exercise | Warrant (right to buy) | 115.3k | $0.74 | $85.3k | | 07/11/2023 |
| 07/11/2023 | Jermasek Douglas | EVP of Corporate Strategy | Exercise | Warrant (right to buy) | 72k | $0.59 | $42.5k | | 07/11/2023 |
| 07/11/2023 | Jermasek Douglas | EVP of Corporate Strategy | Exercise | Warrant (right to buy | 79.3k | $0.54 | $42.8k | | 07/11/2023 |
| 07/11/2023 | Jermasek Douglas | EVP of Corporate Strategy | Exercise | Series A-1 Convertible Preferred Stock | 50 | $0.49 | $24.5 | | 07/11/2023 |
| 07/11/2023 | Jermasek Douglas | EVP of Corporate Strategy | Exercise | Common Stock | 104.6k | $0.00 | $0 | | 07/11/2023 |
| 07/11/2023 | Gupta Pramod | EVP, Pharmaceuticals and BD | Exercise | Common Stock | 41.8k | $0.00 | $0 | | 07/11/2023 |
| 03/08/2023 | Jermasek Douglas | EVP of Corporate Strategy | Grant | Series A Convertible Preferred Stock | 50 | $1,000.00 | $50k | | 03/08/2023 |
| 03/08/2023 | Aggarwal Gaurav | Director | Grant | Series A-1 Convertible Preferred Stock | 8.1k | $1,000.00 | $8.1M | By Vivo Opportunity Fund Holdings, L.P. | 03/08/2023 |
| 03/08/2023 | Gupta Shalabh K. | CEO | Grant | Series A Convertible Preferred Stock | 50 | $1,000.00 | $50k | | 03/08/2023 |
| 03/08/2023 | Gupta Pramod | EVP, Pharmaceuticals and BD | Grant | Series A Convertible Preferred Stock | 20 | $1,000.00 | $20k | | 03/08/2023 |
| 11/21/2022 | Gupta Shalabh K. | CEO | Grant | Stock Options | 86k | $0.75 | $64.5k | | 11/21/2022 |
| 11/21/2022 | Townsend John | CFO | Grant | Stock Options | 35k | $0.75 | $26.2k | | 11/21/2022 |
| 11/21/2022 | Jermasek Douglas | EVP of Corporate Strategy | Grant | Stock Options | 55k | $0.75 | $41.2k | | 11/21/2022 |
| 11/21/2022 | Gupta Pramod | EVP, Pharmaceuticals and BD | Grant | Stock Options | 28k | $0.75 | $21k | | 11/21/2022 |
| 07/15/2022 | Schiller Brigitte | Director | Exercise | Restricted Stock Units | 26.7k | $0.00 | $0 | | 07/15/2022 |
| 05/16/2022 | Schiller Brigitte | Director | Purchase | Common Stock | 15k | $0.83 | $12.4k | | 05/16/2022 |
| 07/15/2021 | Gupta Pramod | EVP, Pharmaceuticals and BD | Grant | Stock Options | 34.9k | $5.00 | $174.4k | | 07/15/2021 |
| 07/15/2021 | Townsend John | CFO | Grant | Stock Options | 18.6k | $5.00 | $93k | | 07/15/2021 |
| 07/15/2021 | Gupta Shalabh K. | CEO | Grant | Stock Options | 116.3k | $5.00 | $581.4k | | 07/15/2021 |